Skip to main content
SpringerLink
Log in

Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma

  • Original Article
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Purpose

To investigate the prognostic factors of peripheral-type intrahepatic cholangiocarcinoma (PP-IHCC) and evaluate the surgical outcomes according to surgical strategy alterations.

Methods

Twenty-two patients were divided into two groups according to the surgical strategy: an extended surgery group (Ex group: n = 10), composed of those who underwent hepatic lobectomy combined with lymph node (LN) dissection and bile duct resection; and a customized surgery group (Cx group: n = 12), composed of those who underwent hepatectomy and bile duct resection according to tumor spread. LN dissection was not performed in patients without LN metastasis.

Results

Multivariate analysis revealed that R2 resection, LN metastasis, and intrahepatic metastasis were independent prognostic factors. LN dissection was significantly infrequent in the Cx group. Survival after curative resection was similar in the two groups (3-year survival: 42.9 vs. 57.1%). Liver metastasis was the most frequent primary recurrence, occurring in more than 80% of patients from both groups.

Conclusions

Curative surgery might improve the prognosis of patients with PP-IHCC, but routine LN dissection is not recommended, particularly for patients without LN metastasis. Surgery alone, including LN dissection, cannot control this type of tumor, and additional treatment should be given.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. The Liver Study Group of Japan. The 16th report: surveillance of primary liver cancer patients in National Registry. Kyoto: LCSGJ; 2005.

  2. Washburn WK, Lewis WD, Jenkins RL. Aggressive surgical resection for cholangiocarcinoma. Arch Surg. 1995;130:270–6.

    Article  PubMed  CAS  Google Scholar 

  3. Roayaie S, Guarrena JV, Ye MQ, Thung SN, Emre S, Fishbein TM, et al. Aggressive surgical treatment of intrahepatic cholangiocarcinoma: predictors of outcomes. J Am Coll Surg. 1998;187:365–72.

    Article  PubMed  CAS  Google Scholar 

  4. Kacznski J, Hanson G, Wallerstedt S. Incidence, etiologic aspects and clinicopathological features in intrahepatic cholangiocarcinoma: a study of 51 cases from a low endemicity area. Acta Oncol. 1988;37:77–83.

    Google Scholar 

  5. Shimada M, Sugimoto K, Iwahashi S, Utsunomiya T, Morine Y, Imura S, et al. CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma. J Gastroenterol. 2010;45:896–902.

    Article  PubMed  CAS  Google Scholar 

  6. Chu KM, Lai ECS, Al-Hadeede S, Arcilla CE Jr, Lo CM, Liu CL, et al. Intrahepatic cholangiocarcinoma. World J Surg. 1997;21:301–6.

    Article  PubMed  CAS  Google Scholar 

  7. Casavila FA, Marsh JW, Iwatsuki S, Todo S, Lee RG, Madariaga R, et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg. 1997;185:429–36.

    Google Scholar 

  8. Chou FF, Sheen-Chen SM, Chen YS, Chen MC, Chen CL. Surgical treatment of cholangiocarcinoma. Hepatogastroenterology. 1997;44:760–5.

    PubMed  CAS  Google Scholar 

  9. Hasegawa K, Kokudo N. Surgical treatment of hepatocellular carcinoma. Surg Today. 2009;39:833–43.

    Article  PubMed  Google Scholar 

  10. Yamamoto M, Takasaki K, Otsubo T, Katsuragawa H, Katagiri S. Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2001;8:154–7.

    Article  PubMed  CAS  Google Scholar 

  11. Miwa S, Miyagawa S, Kobayashi A, Akahane Y, Nakata T, Mihara M, et al. Predictive factors for intrahepatic cholangiocarcinoma recurrence in the following surgery. J Gastroenterol. 2006;41:893–900.

    Article  PubMed  CAS  Google Scholar 

  12. Uenishi T, Kubo S, Yamazaki O, Yamada T, Sasaki Y, Nagano H, et al. Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastasis. J Hepatobiliary Pancreat Surg. 2008;15:417–22.

    Article  PubMed  Google Scholar 

  13. Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery (St. Louis). 2000;127(5):498–505.

    Article  CAS  Google Scholar 

  14. Shimada M, Yamashita Y, Aishima S, Shirabe K, Takenaka K, Sugimachi K. Value of lymph nodes dissection during resection of intrahepatic cholangiocarcinoma. Br J Surg. 2001;88:1463–6.

    Article  PubMed  CAS  Google Scholar 

  15. Liver Cancer Study Group of Japan. Classification of primary liver cancer, 1st English edition. Tokyo: Kanehara; 1997.

  16. Nimura Y, Kamiya J, Nagino M, Kanai M, Uesaka K, Kondo S, et al. Aggressive surgical treatment of hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 1998;5:52–61.

    Article  PubMed  CAS  Google Scholar 

  17. Shirabe K, Shimada M, Harimoto N, Sugimachi K, Yamashita Y, Tsujita E, et al. Intrahepatic cholangiocarcinoma: its mode of spreading and therapeutic modalities. Surgery (St. Louis). 2002;131(1 suppl):S159–64.

    Article  Google Scholar 

  18. Uenishi T, Hirohashi K, Kubo S, Yamamoto T, Yamazaki O, Kinoshita H. Clinicopathological factors predicting outcome after resection of mass-forming intrahepatic cholangiocarcinoma. Br J Surg. 2001;88:969–74.

    Article  PubMed  CAS  Google Scholar 

  19. Inoue K, Makuuchi M, Takayama T, Torzilli G, Yamamoto J, Shimada K, et al. Long-term survival and prognostic factors in the surgical treatment of mass-forming type cholangiocarcinoma. Surgery (St. Louis). 2000;127:498–505.

    Article  CAS  Google Scholar 

  20. Shimada K, Sano T, Nara S, Esaki M, Sakamoto Y, Kosuge T, et al. Therapeutic value of lymph node dissection during hepatectomy in patients with intrahepatic cholangiocellular carcinoma with negative lymph node involvement. Surgery (St. Louis). 2009;145:411–6.

    Article  Google Scholar 

  21. Morimoto Y, Tanaka Y, Ito T, Nakahara M, Nakaba H, Nishida T, et al. Long-term survival and prognostic factors in the surgical treatment for intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg. 2003;10:432–40.

    Article  PubMed  Google Scholar 

  22. Ohtsuka M, Ito H, Kimura F, Shimizu H, Togawa A, Yoshidome H, et al. Results of surgical treatment for intrahepatic cholangiocarcinoma and clinicopathological factors influencing survival. Br J Surg. 2002;89:1525–31.

    Article  PubMed  CAS  Google Scholar 

  23. Nakagawa T, Kamiyama T, Kurauchi N, Matsushita M, Nakanishi K, Kamachi H, et al. Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg. 2005;29:728–33.

    Article  PubMed  Google Scholar 

  24. Suzuki S, Sakaguchi T, Yokoi Y, Okamoto K, Kurachi K, Tsuchiya Y, et al. Clinicopathological prognostic factors and impact of surgical treatment of mass-forming intrahepatic cholangiocarcinoma. World J Surg. 2002;26:687–93.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School, 3-18-15 Kuramoto-cho, Tokushima, 770-8503, Japan

    Yuji Morine, Mitsuo Shimada, Tohru Utsunomiya, Satoru Imura, Tetsuya Ikemoto, Hiroki Mori, Jun Hanaoka, Mami Kanamoto & Hidenori Miyake

Authors
  1. Yuji Morine
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mitsuo Shimada
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tohru Utsunomiya
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Satoru Imura
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tetsuya Ikemoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroki Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jun Hanaoka
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Mami Kanamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Hidenori Miyake
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuji Morine.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Morine, Y., Shimada, M., Utsunomiya, T. et al. Clinical impact of lymph node dissection in surgery for peripheral-type intrahepatic cholangiocarcinoma. Surg Today 42, 147–151 (2012). https://doi.org/10.1007/s00595-011-0057-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-011-0057-9

Keywords

Search

Navigation